Literature DB >> 17238269

Predicting class I major histocompatibility complex (MHC) binders using multivariate statistics: comparison of discriminant analysis and multiple linear regression.

Irini A Doytchinova1, Darren R Flower.   

Abstract

The accurate in silico identification of T-cell epitopes is a critical step in the development of peptide-based vaccines, reagents, and diagnostics. It has a direct impact on the success of subsequent experimental work. Epitopes arise as a consequence of complex proteolytic processing within the cell. Prior to being recognized by T cells, an epitope is presented on the cell surface as a complex with a major histocompatibility complex (MHC) protein. A prerequisite therefore for T-cell recognition is that an epitope is also a good MHC binder. Thus, T-cell epitope prediction overlaps strongly with the prediction of MHC binding. In the present study, we compare discriminant analysis and multiple linear regression as algorithmic engines for the definition of quantitative matrices for binding affinity prediction. We apply these methods to peptides which bind the well-studied human MHC allele HLA-A*0201. A matrix which results from combining results of the two methods proved powerfully predictive under cross-validation. The new matrix was also tested on an external set of 160 binders to HLA-A*0201; it was able to recognize 135 (84%) of them.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17238269     DOI: 10.1021/ci600318z

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  7 in total

1.  A comprehensive analysis of the thermodynamic events involved in ligand-receptor binding using CoRIA and its variants.

Authors:  Jitender Verma; Vijay M Khedkar; Arati S Prabhu; Santosh A Khedkar; Alpeshkumar K Malde; Evans C Coutinho
Journal:  J Comput Aided Mol Des       Date:  2008-01-25       Impact factor: 3.686

2.  Steric recognition of T-cell receptor contact residues is required to map mutant epitopes by immunoinformatical programmes.

Authors:  Shiou-Chih Hsu; Chih-Peng Chang; Chao-Yuan Tsai; Shih-Hung Hsieh; Betty A Wu-Hsieh; Yu-Shu Lo; Jinn-Moon Yang
Journal:  Immunology       Date:  2012-06       Impact factor: 7.397

3.  Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity.

Authors:  Simone A Joosten; Krista E van Meijgaarden; Pascale C van Weeren; Fatima Kazi; Annemieke Geluk; Nigel D L Savage; Jan W Drijfhout; Darren R Flower; Willem A Hanekom; Michèl R Klein; Tom H M Ottenhoff
Journal:  PLoS Pathog       Date:  2010-02-26       Impact factor: 6.823

4.  In silico analysis of six known Leishmania major antigens and in vitro evaluation of specific epitopes eliciting HLA-A2 restricted CD8 T cell response.

Authors:  Negar Seyed; Farnaz Zahedifard; Shima Safaiyan; Elham Gholami; Fatemeh Doustdari; Kayhan Azadmanesh; Maryam Mirzaei; Nasir Saeedi Eslami; Akbar Khadem Sadegh; Ali Eslami Far; Iraj Sharifi; Sima Rafati
Journal:  PLoS Negl Trop Dis       Date:  2011-09-06

5.  Computational prediction of broadly neutralizing HIV-1 antibody epitopes from neutralization activity data.

Authors:  Andrew L Ferguson; Emilia Falkowska; Laura M Walker; Michael S Seaman; Dennis R Burton; Arup K Chakraborty
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

6.  Identification of HLA‑A*1101‑restricted cytotoxic T lymphocyte epitopes derived from epidermal growth factor pathway substrate number 8.

Authors:  Huifang Lu; Baishan Tang; Yanjie He; Weijun Zhou; Jielei Qiu; Yuhua Li
Journal:  Mol Med Rep       Date:  2016-10-25       Impact factor: 2.952

7.  Integrating in silico and in vitro analysis of peptide binding affinity to HLA-Cw*0102: a bioinformatic approach to the prediction of new epitopes.

Authors:  Valerie A Walshe; Channa K Hattotuwagama; Irini A Doytchinova; Mailee Wong; Isabel K Macdonald; Arend Mulder; Frans H J Claas; Pierre Pellegrino; Jo Turner; Ian Williams; Emma L Turnbull; Persephone Borrow; Darren R Flower
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.